Contrary to our expectations, in the current CAD-cohort, dyslipidemia (Figure 3A), total cholesterol (TC) (Figure 3B), and triglyceride (TG) (Figure 3C) did not have any impact on platelet-CXCL16, CXCR6 or serum sCXCL16 levels. The gene discussed is CXCR6; the disease is metabolic syndrome.